Evidence map›Paper›PMID 39289370›Full record

ArticleNature communications2024

Author Correction: NMNAT2 is a druggable target to drive neuronal NAD production.

James R Tribble, Melissa Jöe, Carmine Varricchio, Amin Otmani, Alessio Canovai, Baninia Habchi, Evangelia Daskalakis, Romanas Chaleckis, Andrea Loreto, Jonathan Gilley and 6 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

James R Tribble *Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital; Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0001-8301-7358
Melissa Jöe *Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital; Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0001-8516-4706
Carmine VarricchioSchool of Pharmacy and Pharmaceutical Sciences; Cardiff University, Cardiff, Wales, UK.
Amin OtmaniDepartment of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital; Karolinska Institutet, Stockholm, Sweden.
Alessio CanovaiDepartment of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital; Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0009-0007-9229-4710
Baninia HabchiUnit of Integrative Metabolomics, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.ORCID http://orcid.org/0000-0001-9705-167X
Evangelia DaskalakisUnit of Integrative Metabolomics, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.
Romanas ChaleckisUnit of Integrative Metabolomics, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.ORCID http://orcid.org/0000-0001-8042-1005
Andrea LoretoJohn van Geest Centre for Brain Repair, Department of Clinical Neurosciences; University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0001-6535-6436
Jonathan GilleyJohn van Geest Centre for Brain Repair, Department of Clinical Neurosciences; University of Cambridge, Cambridge, UK.
Craig E WheelockUnit of Integrative Metabolomics, Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-8113-0653
Gauti JóhannessonDepartment of Clinical Sciences, Ophthalmology, Umeå University, 901 85, Umeå, Sweden.
Raymond C B WongCentre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia.ORCID http://orcid.org/0000-0002-8092-9455
Michael P ColemanJohn van Geest Centre for Brain Repair, Department of Clinical Neurosciences; University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-9354-532X
Andrea BrancaleSchool of Pharmacy and Pharmaceutical Sciences; Cardiff University, Cardiff, Wales, UK.ORCID http://orcid.org/0000-0002-9728-3419
Pete A WilliamsDepartment of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital; Karolinska Institutet, Stockholm, Sweden. pete.williams@ki.se.ORCID http://orcid.org/0000-0001-6194-8397

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39289370
PMCPMC11408734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.